Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSARIO, DENNIS | 1 | 68.9% | +28.8% |
| PHAM, TUAN A | 1 | 83.8% | +26.9% |
| VAN DRUFF, SYDNEY | 1 | 55.6% | +30.6% |
| JADHAO, SAMADHAN JAISING | 1 | 50.0% | +47.1% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 58.5% | +60.8% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 47.6% | +50.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18111875 | Methods of Profiling Mass Spectral Data Using Neural Networks | PHAM, TUAN A | 98d overdue |
| 17922315 | NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER IMMUNOTHERAPY | VAN DRUFF, SYDNEY | — |
| 17911341 | METHODS AND KITS FOR THE DETECTION OF SARS-COV-2 | JADHAO, SAMADHAN JAISING | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18111875 | Methods of Profiling Mass Spectral Data Using Neural Networks | PHAM, TUAN A | 98d overdue |
| 18656551 | METHODS OF DETECTING SOMATIC AND GERMLINE VARIANTS IN IMPURE TUMORS | ROSARIO, DENNIS | 22d |
| 17922315 | NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER IMMUNOTHERAPY | VAN DRUFF, SYDNEY | — |
| 17911341 | METHODS AND KITS FOR THE DETECTION OF SARS-COV-2 | JADHAO, SAMADHAN JAISING | — |
| 17625333 | METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA | SCHLOOP, ALLISON ELIZABETH | — |
| 17621528 | DETECTION AND TREATMENT OF RESIDUAL DISEASE USING CIRCULATING TUMOR DNA ANALYSIS | BUCHANAN, BAILEY CHEYENNE | — |
| Art Unit | Apps |
|---|---|
| 2676 | 1 |
| 2163 | 1 |
| 1643 | 1 |
| 1672 | 1 |
| 1683 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18656551 | METHODS OF DETECTING SOMATIC AND GERMLINE VARIANTS IN IMPURE TUMORS | ROSARIO, DENNIS | 2676 | §103 | Final Rejection | 22d | Pending | May 06, 2024 |
| 18111875 | Methods of Profiling Mass Spectral Data Using Neural Networks | PHAM, TUAN A | 2163 | §101§103Other | Final Rejection | 98d overdue | Pending | Feb 20, 2023 |
| 17922315 | NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER IMMUNOTHERAPY | VAN DRUFF, SYDNEY | 1643 | §102§103§112 | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17911341 | METHODS AND KITS FOR THE DETECTION OF SARS-COV-2 | JADHAO, SAMADHAN JAISING | 1672 | §103§112 | Final Rejection | — | Pending | Sep 13, 2022 |
| 17625333 | METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Non-Final OA | — | Pending | Jan 06, 2022 |
| 17621528 | DETECTION AND TREATMENT OF RESIDUAL DISEASE USING CIRCULATING TUMOR DNA ANALYSIS | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Non-Final OA | — | Pending | Dec 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial